Ruacho G, Lira-Junior R, Gunnarsson I, Svenungsson E, Bostrom E
Lupus Sci Med. 2022; 9(1).
PMID: 35246487
PMC: 8900065.
DOI: 10.1136/lupus-2021-000607.
Lindblom J, Mohan C, Parodis I
Brain Sci. 2022; 12(2).
PMID: 35203955
PMC: 8869794.
DOI: 10.3390/brainsci12020192.
Diaz-Gallo L, Oke V, Lundstrom E, Elvin K, Wu Y, Eketjall S
ACR Open Rheumatol. 2021; 4(1):27-39.
PMID: 34658170
PMC: 8754019.
DOI: 10.1002/acr2.11343.
Papa N, Minniti A, Maglione W, Pignataro F, Caporali R, Vitali C
Biomolecules. 2021; 11(7).
PMID: 34203480
PMC: 8301983.
DOI: 10.3390/biom11070953.
Pisetsky D, Spencer D, Mobarrez F, Fuzzi E, Gunnarsson I, Svenungsson E
Clin Immunol. 2020; 212:108349.
PMID: 31982644
PMC: 10538439.
DOI: 10.1016/j.clim.2020.108349.
High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V, Gunnarsson I, Dorschner J, Eketjall S, Zickert A, Niewold T
Arthritis Res Ther. 2019; 21(1):107.
PMID: 31036046
PMC: 6489203.
DOI: 10.1186/s13075-019-1878-y.
Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
Fatemi A, Raeisi A, Sayedbonakdar Z, Smiley A
Clin Rheumatol. 2017; 37(4):955-962.
PMID: 29256112
DOI: 10.1007/s10067-017-3949-2.
IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I
Arthritis Res Ther. 2017; 19(1):139.
PMID: 28619037
PMC: 5471711.
DOI: 10.1186/s13075-017-1344-7.
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson J, Herlitz Lindberg M, Gunnarsson I, Pettersson S, Elvin K, Ohrvik J
PLoS One. 2017; 12(4):e0174572.
PMID: 28414714
PMC: 5393555.
DOI: 10.1371/journal.pone.0174572.
Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
Mobarrez F, Vikerfors A, Gustafsson J, Gunnarsson I, Zickert A, Larsson A
Sci Rep. 2016; 6:36025.
PMID: 27777414
PMC: 5078765.
DOI: 10.1038/srep36025.
Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus.
Meshaal S, El Refai R, El Saie A, El Hawary R
Clin Rheumatol. 2016; 35(6):1515-20.
PMID: 27041383
DOI: 10.1007/s10067-016-3250-9.
Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity.
Choi C, Liang M, Bae S
Arthritis Res Ther. 2016; 18:1.
PMID: 26732314
PMC: 4718037.
DOI: 10.1186/s13075-015-0906-9.
Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research.
Mikdashi J, Nived O
Arthritis Res Ther. 2015; 17:183.
PMID: 26189728
PMC: 4507322.
DOI: 10.1186/s13075-015-0702-6.
Predictors of arthritis in pediatric patients with lupus.
Sule S, Moodalbail D, Burnham J, Fivush B, Furth S
Pediatr Rheumatol Online J. 2015; 13:30.
PMID: 26170222
PMC: 4499875.
DOI: 10.1186/s12969-015-0027-7.
Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.
Hawro T, Bogucki A, Krupinska-Kun M, Maurer M, Wozniacka A
PLoS One. 2015; 10(3):e0119911.
PMID: 25781014
PMC: 4362944.
DOI: 10.1371/journal.pone.0119911.
Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Klonowska-Szymczyk A, Wolska A, Robak T, Cebula-Obrzut B, Smolewski P, Robak E
Mediators Inflamm. 2014; 2014:381418.
PMID: 24692849
PMC: 3955595.
DOI: 10.1155/2014/381418.
Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.
Somers E, Marder W, Cagnoli P, Lewis E, DeGuire P, Gordon C
Arthritis Rheumatol. 2014; 66(2):369-78.
PMID: 24504809
PMC: 4198147.
DOI: 10.1002/art.38238.
Cutaneous lupus erythematosus: diagnosis and treatment.
Okon L, Werth V
Best Pract Res Clin Rheumatol. 2013; 27(3):391-404.
PMID: 24238695
PMC: 3927537.
DOI: 10.1016/j.berh.2013.07.008.
A research study of the association between maternal microchimerism and systemic lupus erythematosus in adults: a comparison between patients and healthy controls based on single-nucleotide polymorphism using quantitative real-time PCR.
Kanold A, Svenungsson E, Gunnarsson I, Gotherstrom C, Padyukov L, Papadogiannakis N
PLoS One. 2013; 8(9):e74534.
PMID: 24040274
PMC: 3770650.
DOI: 10.1371/journal.pone.0074534.
New-onset systemic lupus erythematosus during pregnancy.
Zhao C, Zhao J, Huang Y, Wang Z, Wang H, Zhang H
Clin Rheumatol. 2013; 32(6):815-22.
PMID: 23358829
DOI: 10.1007/s10067-013-2180-z.
